Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Experimental and Molecular Pathology
|
September 17, 2013
Angiocidin induces differentiation of acute myeloid leukemia cells
George P Tuszynski, Vicki L Rothman
The Journal of Surgical Research
|
November 22, 2002
Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer
Daniel Albo, Tetsuo Shinohara, George P Tuszynski
Seminars in Thrombosis and Hemostasis
|
March 23, 2004
Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis
Irene Sargiannidou, Cuie Qiu, George P Tuszynski
Surgery
|
September 10, 2002
Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production
Thomas N Wang, Daniel Albo, George P Tuszynski
Current Pharmaceutical Design
|
February 3, 2004
Antiangiogenic therapy
Daniel Albo, Thomas N Wang, George P Tuszynski
Journal of Cellular Biochemistry
|
January 27, 2004
Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5
Meena R Sharma, George P Tuszynski, Mahesh C Sharma
Experimental and Molecular Pathology
|
November 26, 2009
The interaction of angiocidin with tissue transglutaminase
Darryl Z L'Heureux, Vicki L Rothman, George P Tuszynski
Journal of Oncology
|
July 16, 2010
Thrombospondin-1 (TSP-1) Stimulates Expression of Integrin alpha6 in Human Breast Carcinoma Cells: A Downstream Modulator of TSP-1-Induced Cellular Adhesion
Anitha S John, Vicki L Rothman, George P Tuszynski
Experimental and Molecular Pathology
|
February 5, 2022
G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker, promotes proliferation and invasion of triple negative breast cancer
Xiaoyi Zheng, Frank Chang, Yuan Rong, et al.
Cancer Letters
|
January 23, 2016
Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer
Mahesh C Sharma, George P Tuszynski, Marc R Blackman, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Experimental and Molecular Pathology
|
September 17, 2013
Angiocidin induces differentiation of acute myeloid leukemia cells
George P Tuszynski, Vicki L Rothman
The Journal of Surgical Research
|
November 22, 2002
Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer
Daniel Albo, Tetsuo Shinohara, George P Tuszynski
Seminars in Thrombosis and Hemostasis
|
March 23, 2004
Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis
Irene Sargiannidou, Cuie Qiu, George P Tuszynski
Surgery
|
September 10, 2002
Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production
Thomas N Wang, Daniel Albo, George P Tuszynski
Current Pharmaceutical Design
|
February 3, 2004
Antiangiogenic therapy
Daniel Albo, Thomas N Wang, George P Tuszynski
Journal of Cellular Biochemistry
|
January 27, 2004
Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5
Meena R Sharma, George P Tuszynski, Mahesh C Sharma
Experimental and Molecular Pathology
|
November 26, 2009
The interaction of angiocidin with tissue transglutaminase
Darryl Z L'Heureux, Vicki L Rothman, George P Tuszynski
Journal of Oncology
|
July 16, 2010
Thrombospondin-1 (TSP-1) Stimulates Expression of Integrin alpha6 in Human Breast Carcinoma Cells: A Downstream Modulator of TSP-1-Induced Cellular Adhesion
Anitha S John, Vicki L Rothman, George P Tuszynski
Experimental and Molecular Pathology
|
February 5, 2022
G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker, promotes proliferation and invasion of triple negative breast cancer
Xiaoyi Zheng, Frank Chang, Yuan Rong, et al.
Cancer Letters
|
January 23, 2016
Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer
Mahesh C Sharma, George P Tuszynski, Marc R Blackman, et al.
Page
of 4